Dr. Moyo is BHP’s Laboratory Director and a Research associate with HSPH. He is a former Harvard T.H Chan School of Public Health McGoldrick Fellow Biostatistics, and has completed2 Post-Doctoral Fellowships supported by NIH Fogarty International Center (Global Health Fellow, Harvard HBNU) and Wellcome Trust funded DELTAS SANTHE program (Post-Doc Scientific Fellowship, BHP). His interests include characterization of early HIV-1 Infection, estimating HIV incidence, evolutionary bioinformatics, phylogenetics and molecular epidemiology. He has made a number of significant recent advances in the analysis of HIV recency of infection by incorporating HIV diversity refine cross-sectional incidence estimation and over 140 peer reviewed publications. He has worked on various projects including: evaluation of point-of-care viral load and CD4 devices, early infant treatment, community-based prevention studies, Hepatitis, CMV and HPV genotyping, HIV-1 drug resistance. In 2016, Sikhulile was nominated co- vice Chair of the ACTG/IMPAACT Laboratory Technologist Committee. He participates in various international and local HIV technical working groups. Dr Moyo is a member of the Botswana’s Presidential COVID-19 Task Force Team as a co-Chief Scientist. He is an Investigator & Site-Principal Investigator for some NIH funded projects and is a supervisor/mentor for many fellows/researchers at BHP.